Ligand profile
CHEMBL18966
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_0782 — FAD binding domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL18966- UniProt (similar protein)
P19643- pchembl
- 9.050 (~0.9 nM)
- Target protein
- VK055_0782
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 39.4
- −1 ≤ LogP ≤ 5 4.30
- MW ≤ 500 Da 294.3
- LogP ≤ 5 4.30
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 39.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(COc2ccc3c(C)c(C)c(=O)oc3c2)cc1Cc1ccc(COc2ccc3c(C)c(C)c(=O)oc3c2)cc1
InChI=1S/C19H18O3/c1-12-4-6-15(7-5-12)11-21-16-8-9-17-13(2)14(3)19(20)22-18(17)10-16/h4-10H,11H2,1-3H3InChI=1S/C19H18O3/c1-12-4-6-15(7-5-12)11-21-16-8-9-17-13(2)14(3)19(20)22-18(17)10-16/h4-10H,11H2,1-3H3
GXFXMBTYRNXLMV-UHFFFAOYSA-NGXFXMBTYRNXLMV-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF01593
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL18966 →
- UniProt UniProt P19643 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL18966”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0782.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).